BioSpace News Archive

If you’re planning on looking for a new job at the beginning of the year, now is the time to start your job search prep.

In order to do this without burning bridges and ensure that employees have all their references intact, a resignation letter must be created.

Karuna’s work is primarily focused on psychosis related to schizophrenia and late-stage Alzheimer’s disease, as well as analgesic effects for pain.

AstraZeneca and Daiichi Sankyo presented positive data from their Phase II single-arm DESTINY-Breast01 trial of trastuzumab deruxtecan (DS-8201) in HER2-positive metastatic breast cancer patients who received two or more previous HER-2 targeted regimens.

With $6.5 million in seed funding, Aspen Neuroscience, Inc. launched today with a goal of developing the first autologous cell therapies for Parkinson’s disease.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

BioGenerator-backed company is first to manufacture digital health device in St. Louis

Scientific collaboration to study the anti-inflammatory activity of gut beneficial bacteria, more specifically Christensenella for which LNC Therapeutics holds an exclusive worldwide license

Munich/ Martinsried Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that Medigene’s researchers presented clinical immune monitoring data obtained during the first year of treatment from the ongoing Phase I/II clinical trial with Medigene’s DC vaccine for the treatment of acute myeloid leukemia at the 61st ASH Annual Meeting.

Start Codon cohort companies to receive One Nucleus membership benefits